Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Centre-University of Freiburg, 79106 Freiburg, Germany.
Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Int J Mol Sci. 2021 Sep 29;22(19):10556. doi: 10.3390/ijms221910556.
Medium-chain fatty acids (mc-FAs) are currently applied in the treatment of long-chain fatty acid oxidation disorders (lc-FAOD) characterized by impaired β-oxidation. Here, we performed lipidomic and proteomic analysis in fibroblasts from patients with very long-chain acyl-CoA dehydrogenase (VLCADD) and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHADD) deficiencies after incubation with heptanoate (C7) and octanoate (C8). Defects of β-oxidation induced striking proteomic alterations, whereas the effect of treatment with mc-FAs was minor. However, mc-FAs induced a remodeling of complex lipids. Especially C7 appeared to act protectively by restoring sphingolipid biosynthesis flux and improving the observed dysregulation of protein homeostasis in LCHADD under control conditions.
中链脂肪酸(mc-FAs)目前被应用于长链脂肪酸氧化障碍(lc-FAOD)的治疗中,这些障碍的特征是β-氧化受损。在这里,我们对长链酰基辅酶 A 脱氢酶(VLCADD)和长链 3-羟基酰基辅酶 A 脱氢酶(LCHADD)缺乏症患者的成纤维细胞进行了脂组学和蛋白质组学分析,这些细胞在孵育庚酸(C7)和辛酸(C8)后。β-氧化缺陷引起了明显的蛋白质组学改变,而 mc-FAs 的治疗效果则较小。然而,mc-FAs 诱导了复杂脂质的重塑。特别是 C7 似乎通过恢复神经酰胺生物合成通量和改善 LCHADD 在对照条件下观察到的蛋白质平衡失调发挥了保护作用。